| Dr John Joseph Przygoda, MD | |
|
215 Toll Gate Rd, Warwick, RI 02886-4458 | |
| (401) 732-5900 | |
| (401) 732-9726 |
| Full Name | Dr John Joseph Przygoda |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 215 Toll Gate Rd, Warwick, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538195144 | NPI | - | NPPES |
| 9001663 | Medicaid | RI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 5455 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Joseph Przygoda, MD 215 Toll Gate Rd, Warwick, RI 02886-4458 Ph: (401) 732-5900 | Dr John Joseph Przygoda, MD 215 Toll Gate Rd, Warwick, RI 02886-4458 Ph: (401) 732-5900 |
News Archive
The nanoelectronics research centre imec and Peira, a Belgium-based manufacturer of pharmaceutical and chemical research instruments, jointly developed an innovative slice-tilting instrument for in-vitro research on brain tissue. The new tool enables long-term studying of brain cultures through electronic stimulation and read-out, essential in getting insight into the functioning of the brain.
Improved treatments for people with severe asthma are a 'step closer' after a research team led by the University of Leicester identified a breakthrough in the cause of airway narrowing.
MorphoSys AG's (FSE: MOR; Prime Standard Segment, TecDAX) partner OncoMed Pharmaceuticals today announced that Proceedings of the National Academy of Sciences of the United States of America (PNAS) has published online data demonstrating the potent anti-cancer activity of OMP-18R5, a HuCAL antibody targeting the Wnt pathway, in multiple preclinical human tumor models. OMP-18R5 is currently in Phase 1 clinical testing.
Researchers at Georgetown University Medical Center have discovered that a gene associated with human breast stem cells can stimulate development of mammary cells by activating two critical cancer pathways.
› Verified 5 days ago
Dr. Sterling Leaf Malish, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 401-737-7000 | |
Dr. John David Lowney, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1030 Warwick Ave, Warwick, RI 02888 Phone: 401-467-6257 Fax: 401-785-1191 | |
Dr. Christian Rene Herard, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 300 Tollgate Road, Suite 302, Warwick, RI 02886 Phone: 401-738-4014 Fax: 401-738-4090 | |
John A Gelzhiser, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 401-737-7000 Fax: 401-736-4265 | |
Dr. Michael Seidler, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 125 Metro Center Blvd Ste 2000, Warwick, RI 02886 Phone: 401-921-9202 Fax: 401-921-9212 | |
Murli K Raman, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 455 Tollgate Rd, Brigham & Women's Cardiovascular Associates At Cne, Warwick, RI 02886 Phone: 401-681-4996 Fax: 401-921-6569 | |
Dr. Jennifer F Jarbeau, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 400 Bald Hill Rd Ste 524, Warwick, RI 02886 Phone: 401-737-7313 Fax: 401-737-4207 |